BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5877 related articles for article (PubMed ID: 2477904)

  • 41. Biotherapy with interferon in solid tumors.
    Figlin RA
    Oncol Nurs Forum; 1987; 14(6 Suppl):23-31. PubMed ID: 2447570
    [No Abstract]   [Full Text] [Related]  

  • 42. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of interferon in the therapy of malignant lymphoma.
    McLaughlin P
    Biomed Pharmacother; 1996; 50(3-4):140-8. PubMed ID: 8881370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
    Spiers AS
    Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opportunistic malignancies and the acquired immunodeficiency syndrome.
    Mueller N; Hatzakis A
    Princess Takamatsu Symp; 1987; 18():159-71. PubMed ID: 3506539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pattern of adult malignancies in Zambia (1980-1989) in light of the human immunodeficiency virus type 1 epidemic.
    Patil P; Elem B; Zumla A
    J Trop Med Hyg; 1995 Aug; 98(4):281-4. PubMed ID: 7636927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of interferon on various malignancies].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):194-204. PubMed ID: 6696457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors].
    Nachbaur D; Schwaighofer H; Thaler J; Weyrer W; Fink M; Nussbaumer W; Fritsch E; Niederwieser D
    Wien Klin Wochenschr; 1994; 106(7):201-7. PubMed ID: 8197754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant tumors other than lymphoma and Kaposi's sarcoma in association with HIV infection.
    Tirelli U; Vaccher E; Zagonel V; Rezza G; Palmieri G; Pizzoccaro G; Parrinello AE; Carbone A; Monfardini S
    Cancer Detect Prev; 1988; 12(1-6):267-72. PubMed ID: 3180132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cladribine for the treatment of hematologic malignancies.
    Baltz JK; Montello MJ
    Clin Pharm; 1993 Nov; 12(11):805-13; quiz 860-2. PubMed ID: 7903917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent advances in the management of biotherapy-related side effects: fatigue.
    Piper BF; Rieger PT; Brophy L; Haeuber D; Hood LE; Lyver A; Sharp E
    Oncol Nurs Forum; 1989; 16(6 Suppl):27-34. PubMed ID: 2480583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferons. New additions and indications for use.
    Stadler R; Ruszczak Z
    Dermatol Clin; 1993 Jan; 11(1):187-99. PubMed ID: 7679614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Secondary solid tumors in autologous-peripheral blood stem cell transplantation recipients].
    Fujii H; Ueda Y; Nakagawa H
    Rinsho Ketsueki; 2000 Aug; 41(8):621-7. PubMed ID: 11020988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Eight years of experience in a single institution in hematopoietic stem cell autologous transplantation in malignant hematological diseases and in solid tumors].
    Milone GA; Martínez Rolón J; Fernández II; Corrado CS; Desmery PM; Dignani MC; Juni M; Pavlovsky S
    Medicina (B Aires); 2000; 60(1):115-24. PubMed ID: 10835708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Interferons. Treatment of malignant hemopathies with interferons].
    Guilhot F; Sadoun A; Delwail V
    Ann Med Interne (Paris); 1993; 144(8):548-56. PubMed ID: 7513980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of hematologic diseases with alpha interferon].
    Castaigne S
    Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route].
    Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval TI; Gouveia J; Hayat M; Jasmin C; Schwarzenberg L; Machover D; Ribaud P; de Vassal F; Horoszewicz JP
    Biomed Pharmacother; 1982; 36(3):167-70. PubMed ID: 6758874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Human interferons: biological and clinical promises and premises].
    Jasmin C
    Schweiz Med Wochenschr; 1991 Mar; 121(13):463-6. PubMed ID: 1709521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.
    Foon KA; Roth MS; Bunn PA
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):35-42. PubMed ID: 3532334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 294.